Humanized anti-interleukin-6-receptor antibody (tocilizumab) monotherapy is more effective in slowing radiographic progression in patients with rheumatoid arthritis at high baseline risk for structural damage evaluated with levels of biomarkers, radiography, and BMI: data from the SAMURAI study
Jun Hashimoto, Patrick Garnero, Désirée van der Heijde, Nobuyuki Miyasaka, Kazuhiko Yamamoto, Shinichi Kawai, Tsutomu Takeuchi, Hideki Yoshikawa, Norihiro NishimotoVolume:
21
Language:
english
Pages:
6
DOI:
10.1007/s10165-010-0325-3
Date:
February, 2011
File:
PDF, 191 KB
english, 2011